Bernstein Upgrade Sparks Consensus Reset for Datadog
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
DDOG gained 9.1% over the past week, almost exactly in line with its closest cybersecurity and observability peers. CRWD added 13.3% and CGNT rose the same over the same period, while PANW climbed 11.3%. FTNT was the laggard among the group, up 6.4%. DDOG's move was broadly in the middle of the pack: neither the most crowded name nor the most neglected.
What separates DDOG from that peer group this week is the pace of analyst activity ahead of its November 4 earnings release. Bernstein's Peter Weed made the most consequential move on October 19, upgrading the stock to Outperform from Market Perform and lifting his target from $237 to $350. That followed Mizuho raising its target from $300 to $330 on October 15, and Barclays and RBC both nudging targets higher earlier in the month. The broad direction of travel is clear: targets are moving up across the board. The consensus mean now stands at roughly $293, which implies modest upside from Friday's $269.65 close, but several of the freshest individual targets, including Bernstein's $350 and Mizuho's $330, sit well above that consensus anchor. The Street appears to be in the middle of repricing the stock rather than having finished the job.
The bull case rests on a familiar set of numbers that have kept getting bigger. Revenue grew 36% year over year to $1.12 billion last quarter, beating consensus by around 4%. RPO of $3.47 billion and net revenue retention in the low 120s suggest the customer base is still expanding wallet share. The bear case is less about the top line and more about what sustains it: growth depends heavily on existing customers adding products, competition in observability is intensifying, and a dual-class share structure concentrates voting power with the founders. On valuation, the stock trades at roughly 89 times trailing earnings and 65 times EV/EBITDA, both of which have compressed slightly over the past 30 days as the price has climbed into improving fundamentals rather than deteriorating ones. The forward EPS growth factor ranks in the 85th percentile across the ORTEX universe, which at least partially justifies the multiple. The analyst recommendation divergence score is in the 99th percentile, meaning the consensus is unusually skewed toward positive ratings relative to the broader market.
Short positioning adds relatively little tension to the setup. Short interest holds near 3% of the free float, down fractionally over the week after a brief build in early October that has since unwound. Borrow is cheap at 0.38%, and availability is as loose as it gets. Nothing in the lending market suggests any pressure on existing shorts or demand for new ones. Options positioning has edged toward caution, with the put/call ratio at 0.87 against a 20-day average of 0.84, a z-score of about 1.4. That is mildly elevated but nowhere near the 1.01 it reached at the 52-week high. The modest uptick in the ratio is consistent with investors buying some downside protection ahead of the print without making an aggressive directional call.
Retail attention, as measured by Wikipedia page views, is running at a z-score of 1.68 against DDOG's own 90-day history, one of the higher readings in the recent window. That points to above-average retail interest in the stock right now, which makes sense given the share price momentum and the analyst upgrade cycle. It is a measure of attention, not of what the business is doing operationally. The co-founders remain among the largest individual holders, though CTO Alexis Le-Quoc sold roughly $13.4 million worth of shares on October 7 under a pre-arranged 10b5-1 plan. Those sales were scheduled in advance and carry limited information value on their own; net insider activity over the past 90 days is around negative $34 million, driven almost entirely by planned disposals of this type rather than discretionary selling.
The one data point worth tracking into November 4 is whether the consensus price target closes further on the freshest individual targets. If Bernstein's upgrade prompts additional firms to reprice, the mean could shift enough to put the stock at a material discount to consensus for the first time in months. What actually prints on revenue growth and RPO will determine whether that gap was earned.
Stocks in this article
See the live data behind this article on ORTEX.
Open DDOG on ORTEX →How this article was generated
- Generated
- 24 Oct 2026, 20:34
- Data as of
- 24 Oct 2026, 20:34
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.